Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamiflu in Children Less Than 24 Months With Influenza
NCT00391768Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jan 2007
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, open-label, single-arm trial of oseltamivir in influenza, sponsored by National Institute of Allergy and Infectious Diseases. Primary endpoint: Oseltamivir Carboxylate Area Under the Curve at Day 3. Started Jan 2007; status: completed.
02
Drugs
oseltamivir
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00391768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00391768.